Okta Cl A saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 68 to 73.
How To Invest In Stocks In Both Bull And Bear Markets
IBD's unique rating identifies share price action with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks stacks up against all the other stocks in our database.
Decades of market research shows that the best stocks tend to have an RS Rating of at least 80 in the early stages of their moves. See if Okta Cl A can continue to show renewed price strength and hit that benchmark.
While Okta Cl A is not near an ideal entry right now, see if it is able to form and break out from a proper consolidation.
Earnings growth picked up last quarter from 24% to 32%. But sales fell from 13% to 12%.
The company earns the No. 12 rank among its peers in the Computer Software-Security industry group. Palo Alto Networks, Zscaler and CrowdStrike Holdings are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
